Early use of high-efficacy disease-modifying therapies reduces the risk of progression independent of relapse and MRI activity in patients with relapsing-remitting multiple sclerosis.
Saved in:
| Title: | Early use of high-efficacy disease-modifying therapies reduces the risk of progression independent of relapse and MRI activity in patients with relapsing-remitting multiple sclerosis. |
|---|---|
| Authors: | Guarnaschelli MF; Department of Neurology, Fleni, Buenos Aires, Argentina., Marrodan M; Department of Neurology, Fleni, Buenos Aires, Argentina., Sosa BE; Department of Neurology, Fleni, Buenos Aires, Argentina., Perez Arana CI; Department of Neurology, Fleni, Buenos Aires, Argentina., Farez MF; Department of Neurology, Fleni, Buenos Aires, Argentina., Fiol MP; Department of Neurology, Fleni, Buenos Aires, Argentina., Ysrraelit MC; Department of Neurology, Fleni, Buenos Aires, Argentina., Correale J; Department of Neurology, Fleni, Buenos Aires, Argentina; IQUIFIB, School of Pharmacy and Biochemistry, University of Buenos Aires, Buenos Aires, Argentina. |
| Source: | Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2026 Jun; Vol. 32 (7), pp. 737-746. Date of Electronic Publication: 2026 Apr 29. |
| Publication Type: | Journal Article; Observational Study |
| Journal Info: | Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1477-0970 |
|---|---|
| DOI: | 10.1177/13524585261442036 |
